Isabel Siow1, Keng Siang Lee2, John J Y Zhang3, Seyed Ehsan Saffari4, Adeline Ng5, Barnaby Young6. 1. Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: isabel.siow@yahoo.com.sg. 2. Bristol Medical School, Faculty of Health Sciences, University of Bristol, Bristol, UK. 3. Yong Loo Lin School of Medicine, National University of Singapore, Singapore. 4. Health Services & Systems Research, Duke-NUS Medical School, Singapore. 5. Department of Neurology, National Neuroscience Institute, Singapore; Neuroscience and Behavioural Disorders, Duke-NUS, Singapore. 6. National Centre for Infectious Diseases, Singapore; Department of Infectious diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Abstract
INTRODUCTION: COVID-19 is a multi-system infection which predominantly affects the respiratory system, but also causes systemic inflammation, endothelialitis and thrombosis. The consequences of this include renal dysfunction, hepatitis and stroke. In this systematic review, we aimed to evaluate the epidemiology, clinical course, and outcomes of patients who suffer from stroke as a complication of COVID-19. METHODS: We conducted a systematic review of all studies published between November 1, 2019 and July 8, 2020 which reported on patients who suffered from stroke as a complication of COVID-19. RESULTS: 326 studies were screened, and 30 studies reporting findings from 55,176 patients including 899 with stroke were included. The average age of patients who suffered from stroke as a complication of COVID-19 was 65.5 (Range: 40.4-76.4 years). The average incidence of stroke as a complication of COVID-19 was 1.74% (95% CI: 1.09% to 2.51%). The average mortality of stroke in COVID-19 patients was 31.76% (95% CI: 17.77% to 47.31%). These patients also had deranged clinical parameters including deranged coagulation profiles, liver function tests, and full blood counts. CONCLUSION: Although stroke is an uncommon complication of COVID-19, when present, it often results in significant morbidity and mortality. In COVID-19 patients, stroke was associated with older age, comorbidities, and severe illness.
INTRODUCTION:COVID-19 is a multi-system infection which predominantly affects the respiratory system, but also causes systemic inflammation, endothelialitis and thrombosis. The consequences of this include renal dysfunction, hepatitis and stroke. In this systematic review, we aimed to evaluate the epidemiology, clinical course, and outcomes of patients who suffer from stroke as a complication of COVID-19. METHODS: We conducted a systematic review of all studies published between November 1, 2019 and July 8, 2020 which reported on patients who suffered from stroke as a complication of COVID-19. RESULTS: 326 studies were screened, and 30 studies reporting findings from 55,176 patients including 899 with stroke were included. The average age of patients who suffered from stroke as a complication of COVID-19 was 65.5 (Range: 40.4-76.4 years). The average incidence of stroke as a complication of COVID-19 was 1.74% (95% CI: 1.09% to 2.51%). The average mortality of stroke in COVID-19patients was 31.76% (95% CI: 17.77% to 47.31%). These patients also had deranged clinical parameters including deranged coagulation profiles, liver function tests, and full blood counts. CONCLUSION: Although stroke is an uncommon complication of COVID-19, when present, it often results in significant morbidity and mortality. In COVID-19patients, stroke was associated with older age, comorbidities, and severe illness.
Authors: Geidy E Serrano; Jessica E Walker; Cécilia Tremblay; Ignazio S Piras; Matthew J Huentelman; Christine M Belden; Danielle Goldfarb; David Shprecher; Alireza Atri; Charles H Adler; Holly A Shill; Erika Driver-Dunckley; Shyamal H Mehta; Richard Caselli; Bryan K Woodruff; Chadwick F Haarer; Thomas Ruhlen; Maria Torres; Steve Nguyen; Dasan Schmitt; Steven Z Rapscak; Christian Bime; Joseph L Peters; Ellie Alevritis; Richard A Arce; Michael J Glass; Daisy Vargas; Lucia I Sue; Anthony J Intorcia; Courtney M Nelson; Javon Oliver; Aryck Russell; Katsuko E Suszczewicz; Claryssa I Borja; Madison P Cline; Spencer J Hemmingsen; Sanaria Qiji; Holly M Hobgood; Joseph P Mizgerd; Malaya K Sahoo; Haiyu Zhang; Daniel Solis; Thomas J Montine; Gerald J Berry; Eric M Reiman; Katharina Röltgen; Scott D Boyd; Benjamin A Pinsky; James L Zehnder; Pierre Talbot; Marc Desforges; Michael DeTure; Dennis W Dickson; Thomas G Beach Journal: J Neuropathol Exp Neurol Date: 2022-08-16 Impact factor: 3.148
Authors: Mohamad Syafeeq Faeez Md Noh; Abdul Hanif Khan Yusof Khan; Mohd Naqib Mohd Sabri; Mohd Fandi Al-Khafiz Kamis; Mohd Naim Mohd Yaakob; Ezamin Abdul Rahim; Ahmad Sobri Muda Journal: J Cent Nerv Syst Dis Date: 2022-07-08
Authors: Vijay M Ravindra; Frederik Denorme; Matthew D Alexander; Robert A Campbell; Ramesh Grandhi Journal: Interv Neuroradiol Date: 2022-04-21 Impact factor: 1.764
Authors: Lorenzo Ball; Denise Battaglini; Chiara Robba; Danilo Cardim; Emanuela Moncalvo; Iole Brunetti; Matteo Bassetti; Daniele R Giacobbe; Antonio Vena; Nicolò Patroniti; Patricia R M Rocco; Basil F Matta; Paolo Pelosi Journal: Crit Care Date: 2021-03-19 Impact factor: 9.097
Authors: Thomas G Beach; Lucia I Sue; Anthony J Intorcia; Michael J Glass; Jessica E Walker; Richard Arce; Courtney M Nelson; Geidy E Serrano Journal: medRxiv Date: 2021-03-26